医学
淋巴水肿
腋窝淋巴结清扫术
放射治疗
乳腺癌
前哨淋巴结
辅助放疗
活检
放射科
腋窝
淋巴结
哨兵节点
临床终点
外科
解剖(医学)
癌症
辅助治疗
病态的
乳房切除术
原发性肿瘤
腋窝淋巴结
继发性淋巴水肿
淋巴
肿瘤科
乳房外科
保乳手术
作者
Ji Hwan Jo,Seung Do Ahn,Jinhong Jung,Su Ssan Kim
标识
DOI:10.4048/jbc.2026.0090
摘要
PURPOSE: To evaluate regional control and lymphedema according to radiotherapy field in patients with clinically node-negative (cN0) breast cancer who were diagnosed with pathological N1 (pN1) disease after breast-conserving surgery (BCS) and sentinel lymph node biopsy (SNB), using patients who underwent axillary lymph node dissection (ALND) as the comparison group. METHODS: We retrospectively analyzed 616 patients with cN0/pN1 breast cancer who underwent BCS and received adjuvant radiotherapy between 2012 and 2018. Patients were classified into the SNB (n = 316) or ALND (n = 300) groups according to the axillary surgical procedure performed. Patients received standard-tangent radiotherapy, high-tangent radiotherapy, or comprehensive regional nodal irradiation at the treating physician's discretion. The primary endpoint was regional recurrence-free survival (RRFS), and secondary endpoints included overall survival (OS), disease-free survival (DFS), and breast cancer-related lymphedema (BCRL). RESULTS: = 0.404). CONCLUSION: In patients with cN0/pN1 breast cancer treated with BCS and SNB, adjuvant radiotherapy achieved regional control comparable to that observed after ALND, with markedly lower BCRL. Within the SNB group, more extensive radiotherapy fields were not associated with higher BCRL incidence, suggesting that broader nodal coverage may be delivered without substantially increasing lymphedema risk when ALND is omitted.
科研通智能强力驱动
Strongly Powered by AbleSci AI